TARGET AUDIENCE

EDUCATIONAL OBJECTIVES

Upon completion of this activity, participants will be better able to do the following:

1. Identify the current dyslipidemia guidelines and consensus statements to achieve LDL-C goal
2. Compare available pharmacotherapies that reduce LDL-C
3. Analyze the details of the CVD outcomes trial data for patients on PCSK9 inhibitors, including the diabetic patient subset
4. Prioritize the most current treatment plans for patients with familial hypercholesterolemia
5. Apply current algorithms and treatment models for managing the high-risk patient with dyslipidemia

FACULTY

	Christopher P. Cannon, MD (Program Chair) Professor of Medicine Harvard Medical School Executive Director of Cardiometabolic Trials Baim Institute for Clinical Research Cardiovascular Division Brigham and Women’s Hospital Boston, Massachusetts
	Christie M. Ballantyne, MD Professor of Medicine Vice-Chair of Research-Department of Medicine Chief-Section of Cardiology Chief-Section of Cardiovascular Research Baylor College of Medicine Houston, Texas
	Alan S. Brown, MD Director, Division of Cardiology Advocate Lutheran General Hospital President-Elect, National Lipid Association Co-Director, Cardiology Service Line Advocate Medical Group Clinical Associate Professor Loyola Stritch Medical School Park Ridge, Illinois
	Robert H. Eckel, MD Professor of Medicine Division of Endocrinology, Metabolism, and Diabetes, and Cardiology Charles A. Boettcher II Chair in Atherosclerosis University of Colorado Anschutz Medical Campus Aurora, Colorado
	Robert P. Giugliano, MD, SM Associate Professor of Medicine Harvard Medical School Senior Investigator, TIMI Study Group Cardiovascular Division Brigham and Women's Hospital Boston, Massachusetts
	James A. Underberg, MD, MS Clinical Assistant Professor of Medicine NYU School of Medicine NYU Center for Prevention of Cardiovascular Disease Director Bellevue Hospital Lipid Clinic President-Elect National Lipid Association New York, New York

Disclosure of Conflicts of Interest

Non-faculty: Timothy Hayes, MD, PhD; Emma Boring, Nicole Brestowski and Chelsey Benedek hereby state that neither they nor their spouse/life partner have any financial relationships to products or devices with any commercials interest related to the content of this activity of any amount during the past 12 months.

Financial Support

This activity has been supported by an independent educational grant from Amgen Inc.

Provider Information

This activity is provided by AcademicCME.

Credit Designation Statement

CME INQUIRIES/SPECIAL NEEDS

For all CME inquiries or special needs, please contact please contact admin@academiccme.com or 610.687.3300.

Disclosure of Unlabeled Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Amgen Inc. do not recommend the use of any agent outside of the labeled indications.

Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.